Eikon Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $11.41 |
Previous Close | $11.52 |
Day Range | $11.16-$11.41 |
52W Range | $7.90-$17.40 |
Market Cap | $648.8M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.68 |
News
See moreYahoo Finance • 3 months ago
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
Yahoo Finance • 5 months ago
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
Yahoo Finance • 6 months ago
Catalyst Watch: Jobs report, new Apple products, and a spotlight on software
Yahoo Finance • 6 months ago
Spotify upgraded, First Solar downgraded: Wall Street's top analyst calls
About
CEO | Dr. Roger M. Perlmutter M.D., Ph.D. |
CFO | Dr. Alfred Lloyd Bowie Jr., Ph.D. |
Address | 230 Harriet Tubman Way, Millbrae, CA, United States, 94030 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 384 |